Literature DB >> 16416113

Lithiasis in cystic kidney disease and malformations of the urinary tract.

G Gambaro1, A Fabris, D Puliatta, A Lupo.   

Abstract

The prevalence of renal stones in renal cystic and malformative conditions exceeds the prevalence of renal stones in the general population, suggesting that the above-mentioned cystic and malformative disorders favor stone formation. Urinary stasis is generally assumed to play a major part in the pathogenesis of the nephrolithiasis associated with distorted renal anatomy due to a delayed washout of crystals and risk of urinary infections. However metabolic factors are also important in the pathogenesis of stones in these conditions. Indeed, metabolic abnormalities have been observed in the majority of stone-forming patients with conditions such as horseshoe kidney and ureteropelvic junction obstruction. Five different models of stone formation can be identified, depending on stone composition, risk of infection stones, and pathogenesis of renal cystic and malformative conditions. A proper metabolic evaluation should be conducted to diagnose specific, treatable metabolic disorders, thereby reducing the frequency of recurrent stone disease in these conditions as well.

Entities:  

Mesh:

Year:  2006        PMID: 16416113     DOI: 10.1007/s00240-005-0019-z

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  30 in total

1.  Ureteropelvic junction obstruction and coexisting renal calculi in children: role of metabolic abnormalities.

Authors:  A Tekin; S Tekgul; N Atsu; A Ergen; S Kendi
Journal:  Urology       Date:  2001-03       Impact factor: 2.649

2.  Metabolic risk factors in patients with ureteropelvic junction obstruction and renal calculi.

Authors:  S F Matin; S B Streem
Journal:  J Urol       Date:  2000-06       Impact factor: 7.450

3.  Urinary calcium excretion in children with vesicoureteral reflux.

Authors:  Víctor García-Nieto; Beatriz Siverio; Margarita Monge; Claudia Toledo; Natalia Molini
Journal:  Nephrol Dial Transplant       Date:  2003-03       Impact factor: 5.992

4.  Calcified renal stones and cyst calcifications in autosomal dominant polycystic kidney disease: clinical and CT study in 84 patients.

Authors:  E Levine; J J Grantham
Journal:  AJR Am J Roentgenol       Date:  1992-07       Impact factor: 3.959

5.  Metabolic abnormalities associated with renal calculi in patients with horseshoe kidneys.

Authors:  Ganesh V Raj; Brian K Auge; Dean Assimos; Glenn M Preminger
Journal:  J Endourol       Date:  2004-03       Impact factor: 2.942

Review 6.  Renal stone disease in autosomal dominant polycystic kidney disease.

Authors:  V E Torres; D M Wilson; R R Hattery; J W Segura
Journal:  Am J Kidney Dis       Date:  1993-10       Impact factor: 8.860

7.  Yield of screening urography in young women with urinary tract infection.

Authors:  J H Newhouse; J T Rhea; R X Murphy; R C Pfister
Journal:  Urol Radiol       Date:  1982

8.  Vesicoureteral reflux in the adult. II. Nephropathy, hypertension and stones.

Authors:  V E Torres; R S Malek; J P Svensson
Journal:  J Urol       Date:  1983-07       Impact factor: 7.450

9.  Ureteropelvic junction obstruction with concurrent renal pelvic calculi in the pediatric patient: a long-term followup.

Authors:  D A Husmann; D S Milliner; J W Segura
Journal:  J Urol       Date:  1996-08       Impact factor: 7.450

10.  Urinary stone formation in children with prenatally diagnosed uropathies.

Authors:  A M Rickwood; I Reiner
Journal:  Br J Urol       Date:  1991-11
View more
  18 in total

1.  Urinary Lithogenic Risk Profile in ADPKD Patients Treated with Tolvaptan.

Authors:  Matteo Bargagli; Nasser A Dhayat; Manuel Anderegg; Mariam Semmo; Uyen Huynh-Do; Bruno Vogt; Pietro Manuel Ferraro; Daniel G Fuster
Journal:  Clin J Am Soc Nephrol       Date:  2020-06-11       Impact factor: 8.237

Review 2.  Clinical practice. Calcium kidney stones.

Authors:  Elaine M Worcester; Fredric L Coe
Journal:  N Engl J Med       Date:  2010-09-02       Impact factor: 91.245

3.  Pediatric urolithiasis associated with acute gastroenteritis: an inpatient database study in Japan.

Authors:  Masato Takeuchi; Hideo Yasunaga; Hiroki Matsui; Kiyohide Fushimi
Journal:  Eur J Pediatr       Date:  2017-02-08       Impact factor: 3.183

Review 4.  Metabolic evaluation of urinary lithiasis: what urologists should know and do.

Authors:  Julien Letendre; Jonathan Cloutier; Luca Villa; Luc Valiquette
Journal:  World J Urol       Date:  2014-11-21       Impact factor: 4.226

5.  Educational review: role of the pediatric nephrologists in the work-up and management of kidney stones.

Authors:  Carmen Inés Rodriguez Cuellar; Peter Zhan Tao Wang; Michael Freundlich; Guido Filler
Journal:  Pediatr Nephrol       Date:  2019-01-04       Impact factor: 3.714

6.  Determination of urinary lithogenic parameters in murine models orthologous to autosomal dominant polycystic kidney disease.

Authors:  Renato Ribeiro Nogueira Ferraz; Jonathan Mackowiak Fonseca; Gregory George Germino; Luiz Fernando Onuchic; Ita Pfeferman Heilberg
Journal:  Urolithiasis       Date:  2014-05-10       Impact factor: 3.436

7.  Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients.

Authors:  José L Nishiura; Rodrigo F C A Neves; Samara R M Eloi; Susan M L F Cintra; Sergio A Ajzen; Ita P Heilberg
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-01       Impact factor: 8.237

8.  The risk of melamine-induced nephrolithiasis in young children starts at a lower intake level than recommended by the WHO.

Authors:  Gang Li; Shufang Jiao; Xiangjun Yin; Ying Deng; Xinghuo Pang; Yan Wang
Journal:  Pediatr Nephrol       Date:  2009-09-01       Impact factor: 3.714

9.  Complete staghorn calculus in polycystic kidney disease: infection is still the cause.

Authors:  Zhiguo Mao; Jing Xu; Chaoyang Ye; Dongping Chen; Changlin Mei
Journal:  BMC Nephrol       Date:  2013-08-01       Impact factor: 2.388

10.  Do renal cysts affect the success of extracorporeal shockwave lithotripsy? A retrospective comparative study.

Authors:  Adnan Gücük; Ufuk Oztürk; Uğur Uyetürk; Eray Kemahlı; Güven Akın; M Abdurrahim Imamoğlu; Ahmet Metin
Journal:  Adv Urol       Date:  2013-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.